Table 3.

Clinical Outcomes. Response rates are given for 75 patients evaluable for response. PFS = progression free survival at 2 months is the fraction of all patients alive without progression at the radiological evaluation after two cycles. Median PFS and OS = overall survival is given for the intention-to-treat population and reported using the Kaplan–Meier method.

Endpoint	Categories	N	Data	95% CI
Response rate	Stable disease	45	60%	48–71%
	Progressive disease	30	40%	29–52%
PFS	At 2 months	46	46%	36–56%
	Median	100	2.1 months	1.8–3.4
OS	Median	100	5.2 months	4.3–6.5